Since its establishment in 1972, Eurofarma has been operating in the health industry, producing and marketing products and services to improve people's quality of life. Focused on generating shared value, it operates in the areas of Prescription, Nos-Prescription, Generics, Hospital and Oncology. It offers over 700 products, over 2,000 SKUs and serves 42 medical specialties. In Brazil, it covers 100 therapeutic classes, which represent 70% of prescriptions in the entire market. Operating in 20 countries, with manufacturing facilities in Brazil and industrial parks in six other Latin American countries, it generated net sales of R$ 7.1 billion in 2021, a growth of 23% compared to the previous year, and employs more than 8,100 people.
